Cargando…
Staging recurrent ovarian cancer with (18)FDG PET/CT
The aim of the present study was to evaluate the use of 2-deoxy-2-((18)F)-fluoro-D-glucose ((18)FDG) positron emission tomography (PET)/computed tomography (CT) in patients with suspected ovarian cancer recurrence and describe the distribution of metastasis. A total of 45 female patients who underwe...
Autores principales: | DRAGOSAVAC, SANJA, DERCHAIN, SOPHIE, CASERTA, NELSON M.G., DE SOUZA, GUSTAVO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573129/ https://www.ncbi.nlm.nih.gov/pubmed/23420711 http://dx.doi.org/10.3892/ol.2012.1075 |
Ejemplares similares
-
18F-FDG PET and PET/CT in the Localization and Characterization of Lesions in Patients with Ovarian Cancer
por: Caprio, M.G., et al.
Publicado: (2012) -
Preoperative [(18)F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer
por: Chung, Hyun Hoon, et al.
Publicado: (2012) -
Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast (18)F-FDG PET/MRI compared to (18)F-FDG PET/CT and CT
por: Kirchner, Julian, et al.
Publicado: (2017) -
To Enhance or Not to Enhance? The Role of Contrast Medium (18)F-FDG PET/CT in Recurrent Ovarian Carcinomas
por: Massollo, Michela, et al.
Publicado: (2021) -
(18)F-FDG PET-CT for Staging of Conjunctival Melanoma
por: Damian, Andres, et al.
Publicado: (2013)